Valiant Organics Ltd - 540145 - Board Meeting Intimation for Board Meeting Scheduled To Be Held On Wednesday, August 09, 2023.
Valiant Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2023 ,inter alia, to consider and approve The Audited Standalone & Consolidated Financial results of the Company for the Quarter ended June 30, 2023 and any other Business matter, if required, with the permission of Chair. Valiant Organics Ltd - 540145 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Voting Results of Postal Ballot through remote e-voting along with the report of the Scrutinizer. Valiant Organics Ltd - 540145 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for Quarter ended June 30, 2023. Valiant Organics Ltd - 540145 - Announcement under Regulation 30 (LODR)-Cessation
Intimation of completion of tenure of Independent Director of the Company. Valiant Organics Ltd - 540145 - Closure of Trading Window
Intimation of Closure of Trading Window. Valiant Organics Ltd - 540145 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Postal Ballot Notice. Valiant Organics Ltd - 540145 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Notice of Postal Ballot Valiant Organics Ltd - 540145 - Proposed Initial Public Offering Of Valiant Laboratories Limited
We wish to inform you that the Company''s material subsidiary namely, Valiant Laboratories Limited ('VLL") has filed a draft red herring prospectus dated June 05, 2023 with the Securities and Exchange Board of India ('SEBI') in relation to its proposed Initial Public Offering ('the IPO'). Valiant Organics Ltd - 540145 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Investor/Analyst meeting. Valiant Organics Ltd - 540145 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for Financial Year ended March 31, 2023.